Genetic Risk Factors for Psoriasis in Turkish Population: −1540 C/A, −1512 Ins18, and +405 C/G Polymorphisms within the Vascular Endothelial Growth Factor Gene

키워드

참고문헌 (48)

1. Elder JT., "Psoriasis clinical registries, genetics, and genomics", Ann Rheum Dis, 64(Suppl 2), pp.ii106~ii107 (2005)
2. Trembath RC., "Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis", Hum Mol Genet, 6, pp.813~820 (1997)
3. Schön MP., "Psoriasis", N Engl J Med, 352, pp.1899~1912 (2005)
4. Burden AD., "Genetics of psoriasis : paternal inheritance and a locus on chromosome 6p", J Invest Dermatol, 110, pp.958~960 (1998)
5. Vincenti V., "Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3", Circulation, 93, pp.1493~1495 (1996)
6. Heidenreich R., "Angiogenesis drives psoriasis pathogenesis", Int J Exp Pathol, 90, pp.232~248 (2009)
7. Ribatti D, "The crucial role of vascular permeability factor", vascular endothelial growth factor in angiogenesis : a historical review, 2005, pp.128, 303~309
8. Detmar M, "Evidence for vascular endothelial growth factor (VEGF) as a modifier gene in psoriasis", J Invest Dermatol, 122, pp.xiv~xv (2004)
9. Detmar M., "Overexpression of vascular permeability factor", vascular endothelial growth factor and its receptors in psoriasis, 1994, pp.180, 1141~1146
10. Man XY., "Overexpression of vascular endothelial growth factor(VEGF)receptors on keratinocytes in psoriasis : regulated by calcium independent of VEGF", J Cell Mol Med, 12, pp.649~660 (2008)
11. Zhang Y., "Vascular endothelial growth factor 121 is the predominant isoform in psoriatic scales", Exp Dermatol, 14, pp.758~764 (2005)
12. Bhushan M., "Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis", Br J Dermatol, 141, pp.1054~1060 (1999)
13. Creamer D., "Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor", Arch Dermatol, 138, pp.791~796 (2002)
14. Xia YP., "Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis", Blood, 102, pp.161~168 (2003)
15. Bottomley MJ., "Placenta growth factor(PlGF)induces vascular endothelial growth factor(VEGF)secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid", Clin Exp Immunol, 119, pp.182~188 (2000)
16. Murphy M., "The histopathologic spectrum of psoriasis", Clin Dermatol, 25, pp.524~528 (2007)
17. Creamer D., "Angiogenesis in psoriasis", Angiogenesis, 5, pp.231~236 (2002)
18. Bos JD., "Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonal antibodies", Arch Dermatol Res, 275, pp.181~189 (1983)
19. Kneilling M., "Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice", Arthritis Rheum, 56, pp.1806~1816 (2007)
20. Miotla J., "Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis", Lab Invest, 80, pp.1195~1205 (2000)
21. Watanabe H., "Anti-vascular endothelial growth factor receptor-2(Flk-1", KDR)antibody suppresses contact hypersensitivity, 2004, pp.13, 671~681
22. Ruggiero D., "Genetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphisms", PLoS One, 6, pp.e16982~ (2011)
23. Brogan IJ., "Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene", Hum Immunol, 60, pp.1245~1249 (1999)
24. Watson CJ., "Identification of polymorphisms within the vascular endothelial growth factor(VEGF)gene : correlation with variation in VEGF protein production", Cytokine, 12, pp.1232~1235 (2000)
25. Jiménez-Sousa MA., "Genetic polymorphisms located in TGFB1, AGTR1, and VEGFA genes are associated to chronic renal allograft dysfunction", Cytokine, 58, pp.321~326 (2012)
26. Chen Y., "Polymorphism in the vascular endothelial growth factor A(VEGFA)gene is associated with serum VEGF-A level and disease activity in rheumatoid arthritis : differential effect of cigarette smoking", Cytokine, 58, pp.390~397 (2012)
27. Yang B., "Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus", J Diabetes Complications, 17, pp.1~6 (2003)
28. Kamoun M., "Vascular endothelial growth factor gene polymorphisms and serum levels in Behçet's disease", Tissue Antigens, 72, pp.581~587 (2008)
29. Breunis WB., "Vascular endothelial growth factor gene haplotypes in Kawasaki disease", Arthritis Rheum, 54, pp.1588~1594 (2006)
30. Lambrechts D., "VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death", Nat Genet, 34, pp.383~394 (2003)
31. Boiardi L., "Vascular endothelial growth factor gene polymorphisms in giant cell arteritis", J Rheumatol, 30, pp.2160~2164 (2003)
32. Stevens A., "Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter", Cancer Res, 63, pp.812~816 (2003)
33. Awata T., "A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes", Diabetes, 51, pp.1635~1639 (2002)
34. Barile S., "Vascular endothelial growth factor gene polymorphisms increase the risk to develop psoriasis", Exp Dermatol, 15, pp.368~376 (2006)
35. Young HS., "Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis", J Invest Dermatol, 126, pp.453~459 (2006)
36. Young HS., "Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset", J Invest Dermatol, 122, pp.209~215 (2004)
37. Zablotna M., "Association of psoriasis with the VEGF gene polymorphism in the northern Polish population", J Eur Acad Dermatol Venereol, 27, pp.319~323 (2013)
38. Wongpiyabovorn J., "Association of the CTG(−2578", −460, Tissue Antigens, pp.2008, 72[DOI]
39. Wang Z., "Single nucleotide polymorphisms of VEGF gene and Psoriasis risk", J Dermatol Sci, 49, pp.263~265 (2008)
40. Wu J., "The vascular endothelial growth factor +405 G", C polymorphism in psoriasis, 2010, pp.57, 62~63
41. Lee JH., "Single-nucleotide polymorphisms and haplotypes in the VEGF receptor 3 gene and the haplotype GC in the VEGFA gene are associated with psoriasis in Koreans", J Invest Dermatol, 128, pp.1599~1603 (2008)
42. Butt C., "VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis", BMC Musculoskelet Disord, 8, pp.1~ (2007)
43. Qi M., "Four polymorphisms of VEGF(+405C＞G, -460T＞C, -2578C＞A, and-1154G＞A)in susceptibility to psoriasis : a meta-analysis", DNA Cell Biol, 33, pp.234~244 (2014)
44. Stefanaki I., "Investigation of +405 and-460 polymorphisms of vascular endothelial growth factor in psoriasis and short-term responsiveness to efalizumab therapy", Dermatology, 217, pp.201~202 (2008)
45. Bowes J., "Investigation of IL1, VEGF, PPARG and MEFV genes in psoriatic arthritis susceptibility", Ann Rheum Dis, 71, pp.313~314 (2012)
46. Carlström M., "Lack of evidence for association of VEGF polymorphisms in Swedish patients with psoriasis", J Invest Dermatol, 132, pp.1510~1513 (2012)
47. Lip GY., "Vascular endothelial growth factor and angiogenesis in heart failure", J Card Fail, 11, pp.285~287 (2005)
48. Lenny N., "Transcriptional regulation during myelopoiesis", Mol Biol Rep, 24, pp.157~168 (1997)

관련 논문AI추천